The potential benefits of rapid-acting insulin analogs versus regular human insulin are that the analogs have earlier onset and peak of biologic activity, resulting in lower postprandial glucose levels; a shorter duration of action, resulting in less late-prandial hypoglycemia; and less biologic variab...
The ways being current study used 20 pa- tients to contrast the onset of end of action, action, Commentary: Achieving adequate glycemic control and duration of action of the established basal re- can be for fami- extremely frustrating patients, their and with and their healthcar...
this is the key difference between NPH and regular insulin. Moreover, NPH has a slower onset phase but lasts for a longer period of time. Regular insulin has a rapid onset but wears off in shorter time periods. Besides
The potential benefits of rapid-acting insulin analogs versus regular human insulin are that the analogs have earlier onset and peak of biologic activity, resulting in lower postprandial glucose levels; a shorter duration of action, resulting in less late-prandial hypoglycemia; and less biologic variab...